Product image of Zynyz (Retifanlimab) supplied by GNH India

Zynyz

Active Ingredient:
Retifanlimab
Origin:
EU

Zynyz (Retifanlimab)

Zynyz (retifanlimab) is an immunotherapy for certain cancers, designed to help the immune system recognize and attack tumor cells. This PD-1 inhibitor is administered intravenously under medical supervision. Always consult a healthcare professional for personalized treatment guidance.

Manufacturer / TM Owner

Incyte Biosciences Distribution B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Retifanlimab, sold as Zynyz, is used in the treatment of specific cancers by enhancing the body’s immune response against malignant cells. It is prescribed for patients with advanced or metastatic conditions where immunotherapy may be beneficial. This medication is typically considered when standard treatments have not provided adequate results.

Side Effects

  • As an immunotherapy, retifanlimab works by blocking the PD-1 protein, which can help the immune system identify and target cancer cells more effectively. Patients may experience immune-related responses as the body adjusts to the treatment. Common effects include fatigue, skin reactions, or gastrointestinal discomfort during therapy.

Precautions & Warnings

  • Zynyz should only be administered by a healthcare professional in a clinical setting due to its intravenous route. Patients with autoimmune conditions or those on immunosuppressive therapy may require careful monitoring. Regular check-ups are essential to assess response and manage potential side effects.

Avoid Interactions

  • Retifanlimab may interact with other immunotherapies or medications that suppress the immune system, potentially increasing the risk of adverse effects. Combining it with certain chemotherapy drugs or corticosteroids should be evaluated by a physician. Alcohol use and live vaccines may also warrant caution during treatment.

Frequently Asked Questions

Zynyz is used to treat certain advanced or metastatic cancers by helping the immune system target tumor cells.

Zynyz is given as an intravenous infusion in a healthcare setting under professional supervision.

Patients may experience fatigue, skin reactions, or gastrointestinal discomfort during treatment.

Combining Zynyz with other drugs should be discussed with a healthcare provider to avoid potential interactions.

No, Zynyz requires a prescription and is administered in a clinical environment.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Retifanlimab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT